BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29573032)

  • 1. Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer.
    Verma A; Rich LJ; Vincent-Chong VK; Seshadri M
    J Oral Pathol Med; 2018 May; 47(5):484-491. PubMed ID: 29573032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer.
    Rich LJ; Miller A; Singh AK; Seshadri M
    Theranostics; 2018; 8(8):2064-2078. PubMed ID: 29721063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts.
    Seshadri M; Merzianu M; Tang H; Rigual NR; Sullivan M; Loree TR; Popat SR; Repasky EA; Hylander BL
    Cancer Biol Ther; 2009 Dec; 8(23):2275-83. PubMed ID: 19829072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial.
    Curry J; Johnson J; Tassone P; Vidal MD; Menezes DW; Sprandio J; Mollaee M; Cotzia P; Birbe R; Lin Z; Gill K; Duddy E; Zhan T; Leiby B; Reyzer M; Cognetti D; Luginbuhl A; Tuluc M; Martinez-Outschoorn U
    Laryngoscope; 2017 Aug; 127(8):1808-1815. PubMed ID: 28185288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
    Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
    Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H
    BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
    Huang J; Chunta JL; Amin M; Lee DY; Grills IS; Wong CY; Yan D; Marples B; Martinez AA; Wilson GD
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):485-91. PubMed ID: 22331000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
    Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
    Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.
    Nyflot MJ; Kruser TJ; Traynor AM; Khuntia D; Yang DT; Hartig GK; McCulloch TM; Wiederholt PA; Gentry LR; Hoang T; Jeraj R; Harari PM
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):942-51. PubMed ID: 25659884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.
    Koonce NA; Griffin RJ; Dings RPM
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.
    Bhattacharya A; Tóth K; Mazurchuk R; Spernyak JA; Slocum HK; Pendyala L; Azrak R; Cao S; Durrani FA; Rustum YM
    Clin Cancer Res; 2004 Dec; 10(23):8005-17. PubMed ID: 15585636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.
    Surov A; Stumpp P; Meyer HJ; Gawlitza M; Höhn AK; Boehm A; Sabri O; Kahn T; Purz S
    Oral Oncol; 2016 Jul; 58():14-20. PubMed ID: 27311397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
    Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Age on Disease Progression and Microenvironment in Oral Cancer.
    Vincent-Chong VK; DeJong H; Rich LJ; Patti A; Merzianu M; Hershberger PA; Seshadri M
    J Dent Res; 2018 Oct; 97(11):1268-1276. PubMed ID: 29750890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
    Vahle AK; Hermann S; Schäfers M; Wildner M; Kerem A; Öztürk E; Jure-Kunkel M; Franklin C; Lang S; Brandau S
    Head Neck; 2016 Apr; 38(4):542-9. PubMed ID: 25482887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts.
    Görögh T; Quabius ES; Heidebrecht H; Nagy A; Muffels T; Haag J; Ambrosch P; Hoffmann M
    Int J Cancer; 2016 May; 138(10):2529-38. PubMed ID: 26756583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
    J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.